Pharmaxis Ltd (AU:SNT) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Syntara Limited has announced a proposed issue of nearly 9 million options, each exercisable into one ordinary share at an exercise price of 0.1063, with a three-year expiry. This move is aimed at raising funds through a placement, signaling potential growth and expansion opportunities for the company. Investors in the stock market may find this development worth watching as it could impact Syntara’s stock performance.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.